On June 19, 2008, WOLA Senior Associate John_Walsh testified before Joint Economic Committee of the US Congress (chaired by Senator Jim Webb, Democrat of Virginia) on U.S. drug policy.
To provide our network and partners with concise information on the background to the UNGASS 10-year review, the IDPC has produced an Advocacy Guide that explains the structures, processes and issues involved.
As the process of reviewing the 10-year achievements of the global drug control system continues, the IDPC has been synthesising the wide range of publications and analysis from its members into brief advocacy notes that summarise our positions on the key issues in this review.
As the process of reviewing the 10-year achievements of the global drug control system continues, the IDPC has been synthesising the wide range of publications and analysis from its members into brief advocacy notes that summarise our positions on the key issues in this review.
These two briefings focus on the current domestic and international debates regarding the Bolivian government's defence of the indigenous practice of coca chewing.
This version has only minor changes from the previous version, distributed in April, and will be the final version of the advocacy guide. From now on, a series of IDPC updates on the UN Drug Policy Review will be produced, the first being scheduled for the end of July. The IDPC Advocacy Guide provides an update on the emerging process for the review of global policies on controlled drugs being conducted under the auspices of the United Nations.
From 9 to 11 June 2008, political leaders and senior officials will be meeting at the United Nations Headquarters in New York to once again review challenges, and discuss what actions are necessary to achieve the objective of universal access to effective prevention, treatment and care by the year 2010.
This high-level commission (co-chaired by 3 former presidents, and involving 18 members drawn from public life across Latin America), has been established to examine the development of drug problems in Latin America, and look for alternative policy approaches that are more effective in combating the crime, and social and health problems, that are associated with the drug market.